WHO ICTRP trial
Homoeopathy In Treatment of Schizophrenia
CTRI/2024/03/064281 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/03/064281 |
|---|---|
| Public title | Homoeopathy In Treatment of Schizophrenia |
| Scientific title | Efficacy OF Homoeopathy In Cognitive Improvement Of Patients With Schizophrenia Randomized Control Study - NIL |
| Primary sponsor | Dr Jayashree |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: F200- Paranoid schizophrenia |
| Interventions | Intervention1: Group I: Indicated Homoeopathic medicine: Indicated Homoeopathic medication, with or without conventional medication. Dosage: 30 potencies once a week, gradually will be increasing the potencies depending upon the need of the… |
| Registration date | Mar 18, 2024 |
| Target size | 68 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: